FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma. - Wikidata - wikimedia - TriplyDB

FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma.

FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma.

http://www.wikidata.org/entity/Q34419383

about

Splicing Regulators and Their Roles in Cancer Biology and Therapy Long Intergenic Non-Coding RNAs: Novel Drivers of Human Lymphocyte Differentiation Regulatory non-coding RNA: new instruments in the orchestration of cell death Defective control of pre-messenger RNA splicing in human disease The long non-coding RNA NONHSAG026900 predicts prognosis as a favorable biomarker in patients with diffuse large B-cell lymphoma.MYCNOS functions as an antisense RNA regulating MYCN Long non-coding RNAs and control of gene expression in the immune system.A pathophysiological view of the long non-coding RNA world.Inhibition of methyltransferases accelerates degradation of cFLIP and sensitizes B-cell lymphoma cells to TRAIL-induced apoptosis Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma Long non-coding RNAs in innate and adaptive immunity.Long noncoding RNAs in B-cell development and activation.RBM5 reduces small cell lung cancer growth, increases cisplatin sensitivity and regulates key transformation-associated pathways.LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2.Understanding of leukemic stem cells and their clinical implications.Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs.Microarray expression profiles of long non-coding RNAs in germinal center-like diffuse large B-cell lymphoma.Long noncoding RNAs in T lymphocytes.Bidirectional expression of long ncRNA/protein-coding gene pairs in cancer.Short-Circuiting Gene Regulatory Networks: Origins of B Cell Lymphoma Long noncoding RNAs as regulators of Toll-like receptor signaling and innate immunity.AFAP1-AS1, a long noncoding RNA upregulated in lung cancer and promotes invasion and metastasis.Noncoding RNAs in Cancer Immunology.Antisense Long Noncoding RNA HIF1A-AS2 Is Upregulated in Gastric Cancer and Associated with Poor Prognosis.Alternative splicing and cell survival: from tissue homeostasis to disease.LncRNA AFAP1-AS1 promotes growth and metastasis of cholangiocarcinoma cells.Erythroid mRNA processing: a "splice of life".The long non-coding RNA GAS5 regulates transforming growth factor β (TGF-β)-induced smooth muscle cell differentiation via RNA Smad-binding elements.Targeting Wnt pathway in mantle cell lymphoma-initiating cells.Upregulation of the long non-coding RNA AFAP1-AS1 affects the proliferation, invasion and survival of tongue squamous cell carcinoma via the Wnt/β-catenin signaling pathway.AFAP1-AS1: A novel oncogenic long non-coding RNA in human cancers.Emerging mechanisms of long noncoding RNA function during normal and malignant hematopoiesis.Long noncoding RNA identification in lymphoma.Expression Analysis of Long Non-coding RNAs in the Blood of Multiple Sclerosis Patients.Whole-transcriptome microarray analysis reveals regulation of Rab4 by RBM5 in neurons.Fas-Antisense Long Noncoding RNA and Acute Myeloid Leukemia: Is There any Relation?Long non-coding RNA HOTTIP promotes BCL-2 expression and induces chemoresistance in small cell lung cancer by sponging miR-216a.Control of Immune Cell Homeostasis and Function by lncRNAs.A functional polymorphism in lnc-LAMC2-1:1 confers risk of colorectal cancer by affecting miRNA binding.Etoposide-induced DNA damage affects multiple cellular pathways in addition to DNA damage response.

P2860

Q26798158-0EAA7F9D-7994-4E47-8E95-76EB0B7C4C51 Q26828561-EBA87D5C-6D16-42B8-9CA2-9D6597894636 Q28066784-0BD613FC-053C-4236-9311-089CB36DA586 Q28077564-C808AB5C-A10F-4089-BB8C-F8D6607917F2 Q33798371-9585972E-215F-4A66-88D8-7B53CF637CA0 Q34484148-5CE21F3B-172F-4314-9B46-ED5CACA22ADF Q34616243-4BC0088D-B5F3-42CE-80FF-0F0FD2333C4A Q34957187-ECAC7906-985A-4087-9596-BAA7CB084C8F Q35147669-14818265-5FCD-4F3B-A038-D9263A07970F Q36299700-F6BAEB87-C482-4617-AA21-C86D77C3D67C Q36446804-C35B6AFF-128E-498A-BA64-45AF71BD0144 Q37209773-C3150D63-8320-4D63-80AB-FD90591016EF Q37465032-AC01389E-D8DE-458C-A945-EDA2415B3763 Q37523103-D10340F3-8B34-4118-A974-F1192A998DD2 Q37616010-7603C2C1-B5DF-4DE5-AE8D-F46CF896A850 Q37618835-41884707-2DED-43E4-9882-E0CC94A0F7AD Q38431170-311A6187-A150-4AD9-B48A-CB540B18A6E9 Q38625682-C2271A1C-CE11-407D-A034-7AA6C6C25425 Q38636725-D4CC1730-955E-4129-AD5A-59D4439DEF36 Q38646971-7BE3FFB5-E33C-4C9E-8A88-DD5F1938B556 Q38769321-98A59D1A-DFA3-4785-A471-ADEB827D4E86 Q38846082-21E8959E-21CB-4ED2-90E4-010463D15DFD Q38885490-82EC3D6C-12D0-4476-825D-F6DCADAB71D3 Q38909047-717A8C38-A3FC-4538-9735-F042BDAA58BA Q38968877-45167616-9559-4D16-99D6-329CF688FA22 Q41709505-8E1D19D4-6106-49CE-A513-5F4677429E66 Q42129313-BF1E1751-F1FF-405B-983C-1F1FB0DDC771 Q42511662-7330D82D-3B2C-48F5-A3A9-5F74D758AD8C Q42558443-460BAE45-A134-4934-A615-2E7BB93F212E Q47223739-60082BDF-9C80-40EF-9DE4-3C4FC3C23CB8 Q47618652-61E1B000-2B96-4F27-BC9C-27298C2C4397 Q47657395-0C7FE0D5-A91B-4D03-860B-6E8FD0074CDC Q47848636-7FE3D48F-816D-4EC9-8348-D5B87913CD05 Q47887903-CA140323-516F-4701-83F7-449DA65A83FF Q47938947-81E643CA-A747-41AC-9604-DCDABC5A42BA Q49648834-70B1402F-3F09-47BB-9777-FBEA2086BD3C Q49787300-8F03B9EF-4898-4050-A657-FC9E0C58E1C5 Q50053910-A34B7BDA-1FC3-4B9B-89D5-7020F0064F21 Q53205914-B8F36204-6D18-4D1C-86D1-A302BEE40B5B Q54969815-57D1E452-B37E-43EB-8DB4-F46620158E7B

P2860

FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma.

http://www.wikidata.org/entity/Q34419383

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma.

@ast

FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma.

@en

FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma.

@nl

type

label

FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma.

@ast

FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma.

@en

FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma.

@nl

prefLabel

FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma.

@ast

FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma.

@en

FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma.

@nl

P1433

Q34419383-F741ECEB-CE78-42BA-8900-D4E5BC63C1E4

P1476

Q34419383-BE69BE8C-2A47-418B-BE41-C6474BBC2535

P2093

Q34419383-64F94FDF-D852-45C4-AD5D-4CEAC87A1425

Q34419383-7B70F587-8F1D-4EAD-A652-AA3525466CD7

Q34419383-AEC9E41C-33ED-4993-B814-D79CA87F13A9

Q34419383-BF01C906-703C-42E1-8C96-6B7186F95029

Q34419383-D49C1980-F9DD-4EC9-B8FB-2081F20DAA8C

P2860

Q34419383-0573E58E-619A-471E-AF1B-853E5987460A

Q34419383-081D957E-9C02-40D6-99E1-AAB66F96FFD6

Q34419383-0E9CC4BB-A394-417E-95BA-21BA0EFAD9D6

Q34419383-1993F44E-55DB-434C-A782-235D906ABD33

Q34419383-1C97C038-93F7-47A6-A9F9-0DE4C132292A

Q34419383-1D5C6536-E268-49E4-9A2B-0439A578FB2C

Q34419383-2888E9B4-6369-4CB6-A0CD-B84206A7F998

Q34419383-2ABBA440-3498-4423-8BB8-7A80BBEA93F3

Q34419383-2B9A775A-57AA-43A2-8F75-A8A42E27411F

Q34419383-304F8C89-3BBE-4007-8EFC-E359C4CED707

P2888

Q34419383-1865E5E3-66CD-495D-B3E7-D79FD625CC4B

P304

Q34419383-BD364DC2-4A3C-4C27-A405-358C2876DF1A

P31

Q34419383-C799EF56-E7A7-48A5-B958-6D6A2E4F26E5

P356

Q34419383-378F9B6A-8AC8-4FA2-95B4-A9C89468081D

P433

Q34419383-BBD5AEC6-22EF-4A2B-AF58-4A10A644F2A5

P478

Q34419383-8D723E65-2C0D-4952-BA5D-0DBEA173401D

P50

Q34419383-26CEF215-4717-4B9C-8459-F3A446D3EFFB

Q34419383-439C1C81-B926-472D-8814-38E280EFFF4A

Q34419383-67B874E8-753A-422E-8CCB-5D6F5413F18D

P577

Q34419383-C5645F3D-3C4E-4BFE-A8DE-BDF5757801BA

P5875

Q34419383-C57C7757-E9BA-40B9-99A3-D661885EA248

P6179

Q34419383-192D2536-F8E6-4BA4-926D-F59FA58B8F18

P698

Q34419383-3D4BF415-FF8E-48D5-9B21-3399778C65F9

P932

Q34419383-9157AD85-B357-4FF8-89D0-9473897359E8

P356

P1433

P1476

FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma

@en

P2093

F K Braun

http://www.w3.org/2001/XMLSchema#string

F Samaniego

http://www.w3.org/2001/XMLSchema#string

J F Wise

http://www.w3.org/2001/XMLSchema#string

L W Kwak

http://www.w3.org/2001/XMLSchema#string

S Neelapu

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of differentially expressed genes associated with HER-2/neu overexpression in human breast cancer cells

Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity

Death by splicing: tumor suppressor RBM5 freezes splice-site pairing

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy

A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition

Apoptosis in the pathogenesis and treatment of disease

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

ONCOMINE: a cancer microarray database and integrated data-mining platform

The role of EZH2 in tumour progression

P2888

P304

2376-2387

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/LEU.2014.126

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-04-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262191600

http://www.w3.org/2001/XMLSchema#string

P6179

1046455943

http://www.w3.org/2001/XMLSchema#string

P698

24811343

http://www.w3.org/2001/XMLSchema#string

P932

5827933

http://www.w3.org/2001/XMLSchema#string